SIC NEWS: "In a statement, the National Authority for Medicines and Health Products informs that the medicine in question (Spravato) will now be funded" for hospital use in cases of severe depression.
According to a decision, taken earlier this month, o Spravato, in association with two two antidepressants, may be used on-labell "with strategies strategies combination or potentiation oral, in the depressive depressive current moderate a severe", in adults who have performed previously psychotherapy e have resistance or contraindication à "therapy with electroconvulsive therapy", have not have access or have refused this therapy, according to SIC News.
This information appears in the same day that a group group group, which includes the orders of doctors pharmacists e psychologists e o National Council Council Ethics, presented a set of recommendations for o clinical clinical of psychedelics, defending that be classified as medicines.
This approval represents a significant significant in treatment of depression resistant in Portugal, offering a new therapeutic therapeutic for patients patients did not responded a conventional conventional treatments.
At The Clinic of Change there is a treatment program with scetamine (Spravato) which you can consult here.
Read the full story here.
